Moral Virtue and Inclusive Happiness: From Ancient to Recent in Western and Confucian Traditions

What is the relationship between moral virtue and happiness? Does having moral virtues make their possessors happy? Can one be happy without them? Philosophers provide diverging answers to these questions due to their different understandings of the concept of happiness which has multifarious meanings and senses. In this essay, I compare the representative Western theories of happiness with what may be called “a classical Confucian view” informed by recent scholarship on classical Confucianism. I argue that for classical Confucian philosophers, especially Confucius and Mencius, there are two kinds of happiness: exclusive (or unshared) and inclusive (or shared) happiness. I conclude that moral virtue is necessary for inclusive happiness shared by the virtuous and the recipients of their virtuous actions and/or policies

Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study

IntroductionTigecycline is a potential alternative to trimethoprim-sulfamethoxazole in treating Stenotrophomonas maltophilia infections due to its potent in vitro antimicrobial activity. Clinical evidence regarding the use of tigecycline in the treatment of S. maltophilia infections is scarce. In this study, we assessed the efficacy of tigecycline treating ventilator-associated pneumonia (VAP) due to S. maltophilia in comparison with fluoroquinolones.MethodsThis is a multicenter retrospective cohort study of patients admitted between January 2017 and December 2020 with the diagnosis of VAP caused by S. maltophilia receiving either tigecycline or fluoroquinolones as the definitive therapy ≥ 48 h. Clinical outcomes including 28-day mortality, clinical cure and microbiological cure were analyzed.ResultsOf 82 patients with S. maltophilia VAP included, 46 received tigecycline, and 36 received fluoroquinolones; 70.7% of patients had polymicrobial pneumonia, and the appropriate empiric therapy was applied to only 14.6% of patients. The overall 28-day mortality was 39%. Compared with patients receiving fluoroquinolones, tigecycline therapy resulted in worse clinical cure (32.6% vs. 63.9%, p = 0.009) and microbiological cure (28.6% vs. 59.1%, p = 0.045), while there was no statistical difference between 28-day mortality (47.8% vs. 27.8%, p = 0.105) in the two groups. Similar results were also shown in the inverse probability of treatment weighted univariable regression model and multivariable regression model.ConclusionsThe standard dose of tigecycline therapy was associated with a lower clinical and microbiological cure rate but not associated with an increased 28-day mortality in patients with S. maltophilia VAP compared with fluoroquinolones. Considering the unfavorable clinical outcomes, we therefore recommend against using the standard dose of tigecycline in treating S. maltophilia VAP unless new clinical evidence emerges

Dopant-Free Donor (D)–p–D–p–D Conjugated Hole- Transport Materials for Efficient and Stable Perovskite Solar Cells

Three novel hole-transporting materials (HTMs) using the 4-methoxytriphenylamine (MeOTPA) core were designed and synthesized. The energy levels of the HTMs were tuned to match the perovskite energy levels by introducing symmetrical electron-donating groups linked with olefinic bonds as the bridge. The methylammonium lead triiodide (MAPbI(3)) perovskite solar cells based on the new HTM Z34 (see main text for structure) exhibited a remarkable overall power conversion efficiency (PCE) of 16.1% without any dopants or additives, which is comparable to 16.7% obtained by a p-doped 2,2,7,7-tetrakis-(N,N-di-4-methoxyphenylamino)-9,9-spirobifluorene (spiro-OMeTAD)-based device fabricated under the same conditions. Importantly, the devices based on the three new HTMs show relatively improved stability compared to devices based on spiro-OMeTAD when aged under ambient air containing 30% relative humidity in the dark

Over 20% PCE perovskite solar cells with superior stability achieved by novel and low-cost hole-transporting materials

The exploration of alternative low-cost molecular hole-transporting materials (HTMs) for both highly efficient and stable perovskite solar cells (PSCs) is a relatively new research area. Two novel HTMs using the thiophene core were designed and synthesized (Z25 and Z26). The perovskite solar cells based on Z26 exhibited a remarkable overall power conversion efficiency (PCE) of 20.1%, which is comparable to 20.6% obtained with spiroOMeTAD. Importantly, the devices based-on Z26 show better stability compared to devices based on Z25 and spiroOMeTAD when aged under ambient air of 30% or 85% relative humidity in the dark and under continuous full sun illumination at maximum power point tracking respectively. The presented results demonstrate a simple strategy by introducing double bonds to design hole-transporting materials for highly efficient and stable perovskite solar cells with low cost, which is important for commercial application

An airflow-controlled solvent evaporation route to hollow microspheres and colloidosomes

National Natural Science Foundation of China [51173153, U1205113, 51103122]; Scientific and Technical Project of Fujian Province of China [2009J1009]A facile and large-scale method combining airflow-controlled solvent evaporation and amphiphilic copolymer self-assembly has been developed for the generation of hollow polymer microspheres, colloidosomes or even organic-inorganic hybrid colloidosomes. By replacing traditional agitation with the controllable airflow, this surfactant free route showed promising prospect in the fabrication of microcapsules with closed pore morphology. While the hollow polymer microspheres had an adjustable pore structure, the polymer colloidosomes and the hybrid colloidosomes possessed seamless surfaces, making them suitable for the stable encapsulation of small molecules. The hybrid colloidosomes constructed from polymer and Fe3O4 nanoparticles, and the ternary hybrid colloidosomes derived from polymer, polymer nanospheres and Fe3O4 nanoparticles displayed superparamagnetic properties and were excellent contrast agents for magnetic resonance imaging. More importantly, both hybrid colloidosomes and ternary hybrid colloidosomes exhibited a significant evolution of pore morphology from a closed pore structure to an open pore structure in response to the temperature variation, which induced a controllable release of guest molecules

Investigating the Role of P311 in the Hypertrophic Scar

The mechanisms of hypertrophic scar formation are not fully understood. We previously screened the differentially expressed genes of human hypertrophic scar tissue and identified P311 gene as upregulated. As the activities of P311 in human fibroblast function are unknown, we examined the distribution of it and the effects of forced expression or silencing of expression of P311. P311 expression was detected in fibroblast-like cells from the hypertrophic scar of burn injury patients but not in peripheral blood mononuclear cells, bone marrow mesenchymal stem cells, epidermal cells or normal skin dermal cells. Transfection of fibroblasts with P311 gene stimulated the expression of alpha-smooth muscle actin (α-SMA), TGF-β1 and α1(I) collagen (COL1A1), and enhanced the contraction of fibroblast populated collagen lattices (FPCL). In contrast, interference of fibroblast P311 gene expression decreased the TGF-β1 mRNA expression and reduced the contraction of fibroblasts in FPCL. These results suggest that P311 may be involved in the pathogenesis of hypertrophic scar via induction of a myofibroblastic phenotype and of functions such as TGF-β1 expression. P311 could be a novel target for the control of hypertrophic scar development

Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke

Importance It is uncertain whether intravenous methylprednisolone improves outcomes for patients with acute ischemic stroke due to large-vessel occlusion (LVO) undergoing endovascular thrombectomy. Objective To assess the efficacy and adverse events of adjunctive intravenous low-dose methylprednisolone to endovascular thrombectomy for acute ischemic stroke secondary to LVO. Design, Setting, and Participants This investigator-initiated, randomized, double-blind, placebo-controlled trial was implemented at 82 hospitals in China, enrolling 1680 patients with stroke and proximal intracranial LVO presenting within 24 hours of time last known to be well. Recruitment took place between February 9, 2022, and June 30, 2023, with a final follow-up on September 30, 2023.InterventionsEligible patients were randomly assigned to intravenous methylprednisolone (n = 839) at 2 mg/kg/d or placebo (n = 841) for 3 days adjunctive to endovascular thrombectomy. Main Outcomes and Measures The primary efficacy outcome was disability level at 90 days as measured by the overall distribution of the modified Rankin Scale scores (range, 0 [no symptoms] to 6 [death]). The primary safety outcomes included mortality at 90 days and the incidence of symptomatic intracranial hemorrhage within 48 hours. Results Among 1680 patients randomized (median age, 69 years; 727 female [43.3%]), 1673 (99.6%) completed the trial. The median 90-day modified Rankin Scale score was 3 (IQR, 1-5) in the methylprednisolone group vs 3 (IQR, 1-6) in the placebo group (adjusted generalized odds ratio for a lower level of disability, 1.10 [95% CI, 0.96-1.25]; P = .17). In the methylprednisolone group, there was a lower mortality rate (23.2% vs 28.5%; adjusted risk ratio, 0.84 [95% CI, 0.71-0.98]; P = .03) and a lower rate of symptomatic intracranial hemorrhage (8.6% vs 11.7%; adjusted risk ratio, 0.74 [95% CI, 0.55-0.99]; P = .04) compared with placebo. Conclusions and Relevance Among patients with acute ischemic stroke due to LVO undergoing endovascular thrombectomy, adjunctive methylprednisolone added to endovascular thrombectomy did not significantly improve the degree of overall disability.Trial RegistrationChiCTR.org.cn Identifier: ChiCTR210005172

Early Confucian ethics and moral sentimentalism

In this dissertation, the author compares early Confucian ethics with some forms of moral sentimentalism. The ethical views of two Confucian moralists, Kongzi (Confucius) and Mengzi (Mencius) are compared with Michael Slote\u27s agent-based moral sentimentalist virtue ethics and Nel Noddings\u27 feminine relational ethics of caring; the Confucian ethicist Xunzi\u27s theory is compared with David Hume\u27s classical version of moral sentimentalism. Through argumentation and theoretical reconstruction, the author attempts to establish that (1) Kongzi and Mengzi\u27s ethical accounts are agent-based while Xunzi\u27s is agent-prior; (2) Kongzi\u27s notion of shu, Mengzi\u27s concept of ceyin zhi xin, and Xunzi\u27s idea of inner constitution represent different forms of empathy. The author proposes the notion of relational virtue to reconcile the virtue ethical conception of caring with the relational ethical conception of caring. Through these comparisons and the reconciliation the author emphasizes the common ground Confucian ethics shares with the moral sentimentalist tradition. This work as the whole, therefore, represents a radical departure from traditional comparative studies that tend to emphasize the affinity between early Confucian ethics and the ancient Greek tradition